Aristocrat Leisure Limited reports: Should you buy?

Currency swings made for a 10% rise in normalised profit; here's what else you need to know about Aristocrat Leisure Limited's (ASX:ALL) full-year report.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: While shares in gambling business Aristocrat Leisure Limited (ASX: ALL) dipped in the lead up to the annual report, they have since recovered most of their ground with investors apparently liking what they saw despite the company reporting a statutory loss.

Here are the key metrics:

  • Revenue increased 6.9%, or 1.7% on a constant-currency basis
  • Earnings per share rose 6.7% or -2.1% on a constant-currency basis
  • Underlying NPAT rose 10.2% to $118.1m, or up 1.3% on a constant-currency basis
  • Statutory NPAT saw a total loss of $16.4m on impairments and divestments
  • Dividends per share increased 10% to 16cps (up from 14.5cps previously)
  • Strong performance in USA and Aus/NZ regions offset by weakness in Latin America and Japan

So What?

Overall it was a bit of a mixed bag for Aristocrat, with currency fluctuations driving most of the improvement.

A strong performance in the US and ANZ region is a great positive and bodes well for Aristocrat's competitive offering against Ainsworth Game Technology Limited (ASX: AGI) in those markets.

However regulatory changes in Japan resulted in fewer and slower game releases, and management – believing that this slower pace may persist for the foreseeable future – booked a $72.6 million impairment against its Japan Pachislot business.

This was joined by a $43.4 million loss in the company's divestment of its Lotteries business, and $17.1 million in one-off costs associated with the acquisition and restructure of VGT back in July.

Together the charges are responsible for Aristocrat's statutory loss on paper; although in this case it is not appropriate to simply look at underlying profit and rule out the statutory loss.

Shareholders need to take note of both since the loss on the Lotteries sale represents a poor initial investing decision and is very material to the company's ongoing performance. A company's ability to invest its funds into new businesses also determines its status as an appealing investment (or not).

The acquisition charges are nothing to worry about – this thing happens all the time.

The Pachislot impairments could reasonably be placed into either the 'worry' or 'don't worry' categories.

On one hand, a changed regulatory environment in Japan is very relevant to the company's profitability in future periods. On the other, the impairment charge relates mostly to inventory and intangible assets, and doesn't impinge on cash flow, debt or returns to shareholders.

Now What?

As I hope I've made clear, Aristocrat's report is one case where investors need to pay close attention to both the statutory, constant-currency, and underlying figures.

It's difficult to evaluate the company's future since so much of these results were driven by currency effects – strong performances in some regions notwithstanding.

Aristocrat doesn't appear to be a bad investment at all, but there are other companies I find considerably more appealing at the moment.  One of them is The Motley Fool's Top Stock for 2015, a tech business with outstanding competitive advantages, low costs and very appealing plans for expansion into a booming south-east Asia.

Motley Fool contributor Sean O'Neill doesn't own shares in any company mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »